A small molecule inhibitor that attacks the difficult to target, cancer-causing gene mutation KRAS, found in nearly 30 percent of all human tumors, successfully shrunk tumors or stopped cancer growth in preclinical models ...
Dec 6, 2022
0
11
New research published in Cell Death & Disease covers the first batch of results from collaborative work directed to perform multi-omics-based analyses in the context of age-related diseases using an AI-driven target and ...
Dec 1, 2022
0
4
Understanding how cancer cells evolve from healthy brain cells and evade treatment could open up potential new drug therapies for glioblastomas, one of the most common and lethal brain cancers, new research has revealed.
Nov 29, 2022
0
51
In many cancer types, cancer cells try to survive by escaping attack from the immune system. These cancer cells hijack mechanisms called immune checkpoints to trick the immune system into thinking they are healthy cells. ...
Nov 28, 2022
0
82
Researchers at the University of Waterloo have identified a new method for scheduling radiation therapy that could be as much as 22% more effective at killing cancer cells than current standard radiation treatment regimens.
Nov 28, 2022
0
17
Engineered immune cells, known as CAR T cells, have shown the world what personalized immunotherapies can do to fight blood cancers. Now, investigators have reported highly promising early results for CAR T therapy in a small ...
Nov 23, 2022
0
913
Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system ...
Nov 23, 2022
0
64
Whether you survive a bout with cancer may depend, in part, on where you live.
Nov 18, 2022
0
6
Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality.
Nov 10, 2022
0
1454
Bowel cancers can be grouped into six clinically meaningful subtypes based on patterns of gene interactions commonly seen within tumor cells, according to research published today in eLife.
Nov 8, 2022
0
8
